GLP-1 - GuerillaStockTrading.com https://www.guerillastocktrading.com/tag/glp-1/ Live Free or Die Traying Sun, 25 Aug 2024 20:45:10 +0000 en-US hourly 1 https://wordpress.org/?v=6.6.1 https://www.guerillastocktrading.com/wp-content/uploads/2020/01/cropped-cropped-dollars-32x32.png GLP-1 - GuerillaStockTrading.com https://www.guerillastocktrading.com/tag/glp-1/ 32 32 Think GLP-1 drugs are a miracle? Wait until you hear about the hidden risks that nobody’s talking about! 😳 https://www.guerillastocktrading.com/think-glp-1-drugs-are-a-miracle/ Sun, 25 Aug 2024 20:45:07 +0000 https://www.guerillastocktrading.com/?p=378214 GLP-1 receptor agonists, a class of drugs initially developed to manage type 2 diabetes, have recently gained widespread…

This article Think GLP-1 drugs are a miracle? Wait until you hear about the hidden risks that nobody’s talking about! 😳 appeared first on Guerilla Stock Trading.

]]> Drug approvals are skyrocketing! Why Thermo Fisher is the go-to partner for the biggest breakthroughs 💊 https://www.guerillastocktrading.com/drug-approvals-are-skyrocketing-why-thermo-fisher-is-the-go-to-partner-for-the-biggest-breakthroughs/ Sun, 09 Jun 2024 22:05:44 +0000 https://www.guerillastocktrading.com/?p=375522 Thermo Fisher Scientific (TMO), a leading life sciences company, is experiencing growth due to the expanding GLP-1 drug…

This article Drug approvals are skyrocketing! Why Thermo Fisher is the go-to partner for the biggest breakthroughs 💊 appeared first on Guerilla Stock Trading.

]]> Could this new class of drugs revolutionize healthcare? How GLP-1 drugs are changing the game 🔄 https://www.guerillastocktrading.com/could-this-new-class-of-drugs-revolutionize-healthcare-how-glp-1-drugs-are-changing-the-game-%f0%9f%94%84/ Sun, 09 Jun 2024 21:12:37 +0000 https://www.guerillastocktrading.com/?p=375516 A groundbreaking new class of drugs has emerged from the laboratories of biopharma companies, promising to revolutionize the…

This article Could this new class of drugs revolutionize healthcare? How GLP-1 drugs are changing the game 🔄 appeared first on Guerilla Stock Trading.

]]> Eli Lilly’s Ambitious Expansion Plan: A Game-Changer for GLP-1 Medicines https://www.guerillastocktrading.com/eli-lillys-ambitious-expansion-plan-a-game-changer-for-glp-1-medicines/ Sat, 04 May 2024 20:36:45 +0000 https://www.guerillastocktrading.com/?p=374319 In a bold move poised to reshape the landscape of diabetes and obesity treatment, Eli Lilly announced its…

This article Eli Lilly’s Ambitious Expansion Plan: A Game-Changer for GLP-1 Medicines appeared first on Guerilla Stock Trading.

]]> The Obesity Drug Revolution: A New Era in Weight Loss Treatment https://www.guerillastocktrading.com/the-obesity-drug-revolution-a-new-era-in-weight-loss-treatment/ Sat, 04 May 2024 20:23:04 +0000 https://www.guerillastocktrading.com/?p=374315 In a groundbreaking clinical trial conducted by Novo Nordisk four years ago, a drug called semaglutide demonstrated remarkable…

This article The Obesity Drug Revolution: A New Era in Weight Loss Treatment appeared first on Guerilla Stock Trading.

]]> A Breakthrough in Obesity Treatment: Novo Nordisk’s Experimental Pill Shows Promise https://www.guerillastocktrading.com/a-breakthrough-in-obesity-treatment-novo-nordisks-experimental-pill-shows-promise/ Thu, 07 Mar 2024 21:04:03 +0000 https://www.guerillastocktrading.com/?p=372639 In the ongoing battle against obesity, pharmaceutical companies are constantly striving to develop more effective treatments. Novo Nordisk,…

This article A Breakthrough in Obesity Treatment: Novo Nordisk’s Experimental Pill Shows Promise appeared first on Guerilla Stock Trading.

]]> Eli Lilly’s Strong Finish to 2023 https://www.guerillastocktrading.com/eli-lillys-strong-finish-to-2023/ Tue, 06 Feb 2024 16:36:37 +0000 https://www.guerillastocktrading.com/?p=371559 Eli Lilly (LLY), one of the pharmaceutical giants, concluded 2023 on a high note, surpassing analyst expectations with…

This article Eli Lilly’s Strong Finish to 2023 appeared first on Guerilla Stock Trading.

]]> GSBR-1290: A Promising Oral GLP-1 Receptor Agonist in Diabetes and Obesity https://www.guerillastocktrading.com/gsbr-1290-a-promising-oral-glp-1-receptor-agonist-in-diabetes-and-obesity/ Sat, 23 Dec 2023 14:22:43 +0000 https://www.guerillastocktrading.com/?p=369971 Structure Therapeutics (GPCR) has unveiled exciting updates on its development program for GSBR-1290, a highly selective oral GLP-1…

This article GSBR-1290: A Promising Oral GLP-1 Receptor Agonist in Diabetes and Obesity appeared first on Guerilla Stock Trading.

]]>